Pulsenmore Ltd (PLSM) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Pulsenmore Ltd   (PLSM)


Pulsenmore Ltd 's ROA from the fourth quarter of 2025 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Pulsenmore Ltd 's ROA in the fourth quarter of 2025?
Pulsenmore Ltd achieved a return on average assets (ROA) of 15.57 % in its fourth quarter of 2025, this is above PLSM's average return on assets of 0%.
Pulsenmore Ltd assets over the 12 months ending in its fourth quarter of 2025 are valued at $32 million

ROA has improved compared to 0% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector Pulsenmore Ltd achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the third quarter of 2025 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Total Assets Change -17.76 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 5 0 0 0 0
Return On Assets (TTM) 15.57 % 0 % 0 % 0 % 0 %
PLSM's Total Ranking # # # # #
Total Assets (TTM) in million 32 32 32 32 39
Seq. Total Assets Change -0 % 0 % 0 % -17.76 % -
Seq. Net Income Change - - - - -

PLSM's 5 Years Annual ROA >> Back to PLSM Management Effectiveness >> Compare PLSM ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Pulsenmore Ltd 's Assets $ 32 million PLSM's Balance sheet
Pulsenmore Ltd 's Income $ 5 million Quarterly PLSM's Income Statement
PLSM's Income by Division See PLSM's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 38 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -5 0 0 0 0
Annual Return On Assets -13.02 % - - - -

PLSM's 5 Years Annual ROA >> Back to PLSM Management Effectiveness >> Compare PLSM ROA to its Competitors



More Return On Assets Ratios
PLSM's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PLSM's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PLSM's Competitors
Subscribers only: Roa for Pulsenmore Ltd 's Suppliers
Subscribers only: Return On Assets for PLSM's Customers

You may also want to know
PLSM's Roi PLSM's Inventory Turnover Ratio PLSM's Growth Rates PLSM's Dividend Comparisons
PLSM's Profitability Ratios PLSM's Asset Turnover Ratio PLSM's Dividend Growth
PLSM's Roe PLSM's Valuation Ratios PLSM's Financial Strength Ratios PLSM's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Coherus Oncology inc   42.39 %
Elite Pharmaceuticals Inc   41.21 %
Alpha Tau Medical Ltd  40.35 %
Galmed Pharmaceuticals Ltd   37.04 %
Dariohealth Corp   36.94 %
Abeona Therapeutics Inc   35.76 %
Novavax inc   35.32 %
Medinotec Inc   34.18 %
Zevra Therapeutics Inc   33.84 %
Oramed Pharmaceuticals Inc  33.67 %
Idexx Laboratories Inc  31.91 %
Acadia Pharmaceuticals Inc   29.77 %
Newgenivf Group Limited  29.73 %
Hutchmed china Limited  26.11 %
Petros Pharmaceuticals inc   26.04 %
Adma Biologics Inc   25.98 %
Theravance Biopharma inc   25.35 %
Ptc Therapeutics inc   25.21 %
Qhslab Inc   25.12 %
Medpace Holdings Inc   25.07 %
Mettler toledo International Inc   25.07 %
Compugen Ltd  22.57 %
Lifemd Inc   21.39 %
Catalyst Pharmaceuticals Inc   21.24 %
Iradimed Corporation  20.83 %
Incyte Corporation  20.70 %
Transmedics Group Inc   20.34 %
Eli Lilly And Company  19.76 %
Innoviva Inc   19.19 %
Novo Nordisk A  18.87 %

Date modified: 2026-09-08T15:11:39+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.